United States v. Armando Valdes

Court of Appeals for the Eleventh Circuit·Decided December 19, 2023·No. 22-12837·Unpublished

Opinion

[DO NOT PUBLISH]

In the

United States Court of Appeals For the Eleventh Circuit

No. 22-12837

Non-Argument Calendar

UNITED STATES OF AMERICA, Plaintiff-Appellee,

versus ARMANDO VALDES,

Defendant-Appellant.

Appeal from the United States District Court for the Southern District of Florida D.C. Docket No. 1:21-cr-20590-KMW-1

2 Opinion of the Court 22-12837

Before WILSON, LUCK, and HULL, Circuit Judges. PER CURIAM:

After pleading guilty, Armando Valdes appeals his 60-month sentence for health care fraud, in violation of 18 U.S.C. § 1347. Valdes’s conviction and sentence arise out of his scheme to submit millions of dollars in fraudulent medical claims to United Healthcare and Blue Cross Blue Shield for intravenous infusions of Infliximab, an expensive immunosuppressive drug. These infusions, purportedly given to patients at Valdes’s medical clinic, Gasiel Medical Services (“Gasiel”), were either not provided or were medically unnecessary.

On appeal, Valdes argues that the district court erred by:

(1) applying a 22-level increase in his offense level under U.S.S.G. § 2B1.1(b)(1) because the loss amount exceeded $25 million; (2) applying a two-level increase under U.S.S.G. § 2B1.1(b)(10)(C) for using sophisticated means; (3) applying a two-level increase under U.S.S.G. § 3B1.3 for abusing a position of trust or using a special skill; and (4) ordering the forfeiture of his primary residence as substitute property. After review, we affirm Valdes’s sentence.

I. LOSS AMOUNT

Under U.S.S.G. § 2B1.1(b)(1), a defendant’s offense level increases with the amount of “loss” caused by the offense. In Valdes’s case, his base offense level was increased by 22 levels because the district court found that the loss amount was $38

22-12837 Opinion of the Court 3

million, and thus more than $25 million, as provided in § 2B1.1(b)(1)(L). A. U.S.S.G. § 2B1.1(b)(1)

Section 2B1.1(b)(1)(L) provides that a defendant’s base offense level is increased by 22 levels if the loss from the fraud offense was more than $25 million but less than $65 million. U.S.S.G. § 2B1.1(b)(1)(L),(M). The commentary to § 2B1.1 defines loss as the greater of either the actual loss, which is the “reasonably foreseeable pecuniary harm that resulted,” or the intended loss, which is the “pecuniary harm that the defendant purposely sought to inflict.” Id. § 2B1.1 cmt. n.3(A)(i)-(ii). Intended loss includes harm “that would have been impossible or unlikely to occur.” Id. § 2B1.1 cmt. n.3(A)(ii). Insurance fraud, in which the claim exceeded the insured value, is cited as an example of impossible or unlikely harm. Id.

The Guidelines do not require a precise determination of loss. United States v. Barrington, 648 F.3d 1178, 1197 (11th Cir. 2011). Instead, the district court need make only a reasonable estimate based on the available information. Id.; see also U.S.S.G. § 2B1.1 cmt. n.3(C).

While the government has the burden to prove the loss amount with specific, reliable evidence, the district court may make its factual findings as to the loss amount based on, among other things, evidence presented at trial or sentencing or on the undisputed statements in the presentence investigation report (“PSI”). United States v. Moran, 778 F.3d 942, 973 (11th Cir. 2015).

USCA11 Case: 22-12837 Document: 48-1 Date Filed: 12/19/2023 Page: 4 of 14

4 Opinion of the Court 22-12837

We review a district court’s loss determination for clear error. Barrington, 648 F.3d at 1197. B. Analysis Here, Valdes has not shown the district court’s loss amount of $38 million was clear error. In his factual proffer and at his plea hearing, Valdes admitted that through Gasiel, he submitted approximately $33 million in fraudulent claims to United Healthcare and approximately $5 million in fraudulent claims to Blue Cross Blue Shield. Because there is a strong presumption that those statements are true, United States v. Medlock, 12 F.3d 185, 187 (11th Cir. 1994), the district court could rely on them in determining the loss amount.

Valdes contends some of the $33 million submitted to United Healthcare was attributable to duplicate claims and therefore should not have been included in the intended loss amount. 1 Valdes also claims the intended loss amount “was the 30% contracted payment” under United Healthcare’s pricing payment agreement. There are several problems with Valdes’s arguments.

First, for purposes of the loss amount under § 2B1.1, the intended loss includes unlikely amounts of pecuniary harm, such

1 Valdes has never disputed that the intended loss amount was the appropriate

measure of loss in his case or argued that the definition of loss in the Guidelines commentary should not apply. He has merely argued that duplicate claims should not be part of the intended loss because he did not intend them to be paid.

USCA11 Case: 22-12837 Document: 48-1 Date Filed: 12/19/2023 Page: 5 of 14

22-12837 Opinion of the Court 5

as claims that exceed the insured value. U.S.S.G. § 2B1.1 cmt. n.3(A)(ii); United States v. Moss, 34 F.4th 1176, 1191-92 (11th Cir. 2022) (affirming district court’s use of the amount billed, rather than the amount the defendant expected to be reimbursed, even though it was unlikely the defendant would be paid the full billed amount). Thus, even if United Healthcare was unlikely to reimburse Valdes for the entire amount billed or for duplicate claims, those claims were nonetheless properly included in the intended loss amount.

Second, at the sentencing hearing, Valdes’s own fraud analyst testified that, even accounting for duplicate claims, the total loss amount was above $25 million, the threshold for the 22-level increase in Valdes’s offense level. Further, Valdes did not present any testimony or evidence at sentencing to support his assertion that he intended United Healthcare to reimburse him only 30% of the billed amount. 2 See Moss, 34 F.4th at 1192 (affirming where the defendant did not point to any evidence, such as revenue projections based on the actual reimbursable amount, showing he intended to obtain less than the amount billed). Accordingly, Valdes has not shown clear error in the district court’s determination of the loss amount or its application of the 22-level increase in Valdes’s offense level under § 2B1.1(b)(1).

2 Valdes himself did not testify.

Valdes’s expert testified about the duplicate billing but not about an agreement with United Healthcare to reimburse only 30% of the amount billed.

6 Opinion of the Court 22-12837

II. SOPHISTICATED MEANS ENHANCEMENT Valdes also challenges the district court’s application of a sophisticated means enhancement under U.S.S.G. § 2B1.1. Valdes argues that his offense involved the largely repetitive act of billing for a service that was not provided and was easily detectable. A. U.S.S.G. § 2B1.1(b)(10)(C)

If a defendant’s fraud offense involved sophisticated means, his offense level is increased by two levels. U.S.S.G. § 2B1.1(b)(10)(C). The commentary defines “sophisticated means” as “especially complex or especially intricate offense conduct pertaining to the execution or concealment of an offense.” Id. § 2B1.1 cmt. n.9(B). Hiding assets or transactions using fictitious entities or corporate shells ordinarily indicates sophisticated means. Id.

Whether conduct is sophisticated is based on the conduct as a whole, not on the individual steps. Barrington, 648 F.3d at 1199. Repetitive and coordinated conduct can be a sophisticated scheme even when no one step is particularly complicated. Id. When a large amount of money is stolen gradually and the fraud is not discovered over a long period, the length of time for which the conduct is not detected can reflect the sophistication of the scheme. United States v. Feaster, 798 F.3d 1374, 1381 (11th Cir. 2015).

Free access — add to your briefcase to read the full text and ask questions with AI

United States v. Armando Valdes, (11th Cir. 2023).

United States v. Armando Valdes (United States v. Armando Valdes) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

United States v. David Wayne Monroe
353 F.3d 1346 (Eleventh Circuit, 2003)
United States v. Jason M. Moriarty
429 F.3d 1012 (Eleventh Circuit, 2005)
United States v. Earl Robert Wade
458 F.3d 1273 (Eleventh Circuit, 2006)
United States v. Vonn
535 U.S. 55 (Supreme Court, 2002)
United States v. Barrington
648 F.3d 1178 (Eleventh Circuit, 2011)
United States v. Anthony Roberts
778 F.3d 942 (Eleventh Circuit, 2015)
United States v. Yolanda Sosa
782 F.3d 630 (Eleventh Circuit, 2015)
United States v. Zerry Feaster
798 F.3d 1374 (Eleventh Circuit, 2015)
United States v. Douglas Moss
34 F.4th 1176 (Eleventh Circuit, 2022)
United States v. John J. Utsick
45 F.4th 1325 (Eleventh Circuit, 2022)